Combination endocrine therapy following progression on first-line therapy

被引：0
|
作者：
O'Regan, R.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-ED04-02
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ED04-02
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Are fixed-dose combination antihypertensives suitable as first-line therapy?
    Kjeldsen, Sverre E.
    Messerli, Franz H.
    Chiang, Chern-En
    Meredith, Peter A.
    Liu, Lisheng
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (10) : 1685 - 1697
  • [22] First-line Combination Therapy with Rituximab and Corticosteroids is Effective and Safe for Pemphigus
    Cho, Yung-Tsu
    Lee, Fang-Yu
    Chu, Chia-Yu
    Wang, Li-Fang
    ACTA DERMATO-VENEREOLOGICA, 2014, 94 (04) : 472 - 473
  • [23] Prognostic factors of prostate cancer treated by first-line endocrine therapy.
    Rigaud, J
    Le Normand, L
    Karam, G
    Glemain, P
    Buzelin, JM
    Bouchot, O
    PROGRES EN UROLOGIE, 2002, 12 (02): : 232 - 239
  • [24] Clinical outcomes with first-line chemotherapy versus endocrine therapy for adjuvant endocrine therapy-resistant metastatic breast cancer
    Shao, Bin
    Yang, Yanlian
    Qu, Jinrong
    Li, Huiping
    Song, Guohong
    Di, Lijun
    Jiang, Hanfang
    Yan, Ying
    Wang, Huan
    Liu, Xiaoran
    Wang, Jing
    Kong, Weiyao
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (03) : 676 - 685
  • [25] CLL: State of the Art Therapy, First-line therapy
    Prochazka, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 266 - 266
  • [26] Rituximab As First-Line Maintenance Therapy Following Rituximab-Containing Therapy for Follicular Lymphoma
    Croxtall, Jamie D.
    DRUGS, 2011, 71 (07) : 885 - 895
  • [27] RituximabAs First-Line Maintenance Therapy Following Rituximab-Containing Therapy for Follicular Lymphoma
    Jamie D. Croxtall
    Drugs, 2011, 71 : 885 - 895
  • [28] Bevacizumab as first-line therapy for glioblastoma
    Piccioni, David
    Lai, Albert
    Phioanh Nghiemphu
    Cloughesy, Timothy
    FUTURE ONCOLOGY, 2012, 8 (08) : 929 - 938
  • [29] First-Line Therapy for Immune Thrombocytopenia
    Mithoowani, Siraj
    Arnold, Donald M.
    HAMOSTASEOLOGIE, 2019, 39 (03): : 258 - 265
  • [30] AIH Therapy: Beyond First-Line
    Adao I.
    Klepper A.
    Tana M.
    Current Hepatology Reports, 2024, 23 (3) : 341 - 348
12345